Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Unknown 1Suspended 1Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 16Thoracic 4Head & Neck 4Other solid neoplasm 3Gastrointestinal 3Breast 3Tumor-Agnostic 2Other neoplasm 2Dermatologic 2Sarcoma 1Other hematologic neoplasm 1Other 1Lymphoid 1CNS 1

Conditions

Pancreatic Neoplasms 2Cholangiocarcinoma 1

Interventions

Oxaliplatin 1439Fluorouracil 1319Capecitabine 1114Gemcitabine 1057Leucovorin 939Bevacizumab 847Irinotecan 830Cisplatin 676Radiotherapy 560Cetuximab 482pembrolizumab 435Paclitaxel 401Drug Therapy 358Nivolumab 350130-nm albumin-bound paclitaxel 329Docetaxel 290Sorafenib 288S 1 (combination) 279Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 258lenvatinib 222sintilimab 218tislelizumab 214durvalumab 212regorafenib 209Magnetic Resonance Spectroscopy 205apatinib 204Radiosurgery 204Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Calcitriol × Gastrointestinal × Clear all
NCT00238199 2015-04-24

Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer

OHSU Knight Cancer Institute

Phase 2 Completed
25 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01039181 2009-12-24

Calcitriol in Advanced Intrahepatic Cholangiocarcinoma

National Science and Technology Development Agency, Thailand

Phase 2 Unknown
28 enrolled
Gastrointestinal

Cholangiocarcinoma

NCT00536770 2007-11-06

A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic Cancer

Novacea

Phase 2 Suspended
132 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡